Ubs Group Ag Avanos Medical, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 102,171 shares of AVNS stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,171

Previous 53,769 90.02%

Holding current value

$1.63 Million

Previous $1.07 Million 129.23%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.21 - $24.69 $929,802 - $1.2 Million	48,402 Added 90.02%	102,171 $2.46 Million
Q2 2024 Aug 13, 2024	SELL	$17.85 - $20.42 $463,921 - $530,715	-25,990 Reduced 32.59%	53,769 $1.07 Million
Q1 2024 May 13, 2024	BUY	$17.97 - $22.68 $484,812 - $611,883	26,979 Added 51.12%	79,759 $1.59 Million
Q4 2023 Feb 09, 2024	BUY	$17.64 - $22.99 $391,025 - $509,619	22,167 Added 72.41%	52,780 $1.18 Million
Q3 2023 Nov 09, 2023	SELL	$19.93 - $26.31 $1.98 Million - $2.61 Million	-99,282 Reduced 76.43%	30,613 $618,000
Q2 2023 Aug 11, 2023	BUY	$22.53 - $30.98 $1.49 Million - $2.05 Million	66,333 Added 104.36%	129,895 $3.32 Million
Q1 2023 May 12, 2023	BUY	$26.92 - $31.75 $1.09 Million - $1.29 Million	40,560 Added 176.33%	63,562 $1.89 Million
Q4 2022 Feb 08, 2023	SELL	$19.88 - $27.37 $1,908 - $2,627	-96 Reduced 0.42%	23,002 $622,000
Q3 2022 Nov 10, 2022	BUY	$21.56 - $29.59 $328,445 - $450,774	15,234 Added 193.72%	23,098 $503,000
Q2 2022 Aug 10, 2022	SELL	$24.87 - $34.68 $445,496 - $621,222	-17,913 Reduced 69.49%	7,864 $215,000
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $409,520 - $507,397	14,185 Added 122.37%	25,777 $863,000
Q4 2021 Feb 14, 2022	BUY	$29.25 - $36.02 $52,825 - $65,052	1,806 Added 18.45%	11,592 $402,000
Q3 2021 Nov 15, 2021	SELL	$31.2 - $38.5 $37,034 - $45,699	-1,187 Reduced 10.82%	9,786 $305,000
Q2 2021 Aug 13, 2021	SELL	$36.37 - $45.72 $568,863 - $715,106	-15,641 Reduced 58.77%	10,973 $399,000
Q1 2021 May 12, 2021	BUY	$43.5 - $53.4 $714,270 - $876,828	16,420 Added 161.08%	26,614 $1.16 Million
Q4 2020 Feb 11, 2021	SELL	$33.15 - $49.5 $42,067 - $62,815	-1,269 Reduced 11.07%	10,194 $468,000
Q3 2020 Nov 12, 2020	BUY	$28.67 - $34.32 $4,071 - $4,873	142 Added 1.25%	11,463 $381,000
Q2 2020 Jul 31, 2020	SELL	$23.48 - $33.86 $12,514 - $18,047	-533 Reduced 4.5%	11,321 $333,000
Q1 2020 May 01, 2020	BUY	$20.64 - $34.41 $20,516 - $34,203	994 Added 9.15%	11,854 $319,000
Q4 2019 Feb 14, 2020	SELL	$31.89 - $47.34 $42,796 - $63,530	-1,342 Reduced 11.0%	10,860 $366,000
Q3 2019 Nov 14, 2019	SELL	$32.06 - $44.0 $473,846 - $650,320	-14,780 Reduced 54.78%	12,202 $457,000
Q2 2019 Aug 14, 2019	SELL	$37.68 - $46.52 $1.09 Million - $1.35 Million	-28,917 Reduced 51.73%	26,982 $1.18 Million
Q1 2019 May 14, 2019	BUY	$39.84 - $51.04 $1.04 Million - $1.34 Million	26,173 Added 88.05%	55,899 $2.39 Million
Q4 2018 Feb 14, 2019	SELL	$41.16 - $66.67 $2.47 Million - $4 Million	-60,003 Reduced 66.87%	29,726 $1.33 Million
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $4.95 Million - $6.52 Million	89,729 New	89,729 $6.15 Million

Others Institutions Holding AVNS

# of Institutions

274

Shares Held

42.2M

Call Options Held

5.4K

Put Options Held

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $740M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account